• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎相关的肾单位中的难题。

Hepatitis B related dilemmas in the renal unit.

机构信息

Department of Medicine, Dentistry and Health Science, The University of Melbourne, Melbourne, Victoria, Australia.

Abu Dhabi Health Services Company (SEHA) Kidney Care, Abu Dhabi, UAE.

出版信息

Nephrology (Carlton). 2021 Apr;26(4):287-293. doi: 10.1111/nep.13815. Epub 2020 Nov 12.

DOI:10.1111/nep.13815
PMID:33155307
Abstract

Testing for hepatitis B in dialysis patients is routine, but newer and more sensitive detection methods mean that there is sometimes confusion around viral loads and occult infection. There are frequently difficult choices surrounding isolation and treatment. Here we describe the use of HBV serology and DNA testing in decisions around patients with end-stage renal disease. We also suggest isolation decisions based on our current understanding of the virus and its infectivity.

摘要

对透析患者进行乙型肝炎检测是常规操作,但较新且更敏感的检测方法意味着病毒载量和隐匿性感染有时会令人困惑。在隔离和治疗方面,经常会面临困难的选择。在这里,我们描述了乙型肝炎病毒血清学和 DNA 检测在终末期肾病患者决策中的应用。我们还根据我们目前对病毒及其传染性的了解,提出了隔离决策建议。

相似文献

1
Hepatitis B related dilemmas in the renal unit.乙型肝炎相关的肾单位中的难题。
Nephrology (Carlton). 2021 Apr;26(4):287-293. doi: 10.1111/nep.13815. Epub 2020 Nov 12.
2
Hepatitis B virus among maintainence haemodialysis patients: a report from Karachi, Pakistan.巴基斯坦卡拉奇维持性血液透析患者中的乙型肝炎病毒:一份报告
J Pak Med Assoc. 2011 Dec;61(12):1210-4.
3
Occult hepatitis B virus infection in a cohort of Egyptian chronic hemodialysis patients.一组埃及慢性血液透析患者中的隐匿性乙型肝炎病毒感染
Clin Lab. 2012;58(9-10):1057-61.
4
Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection.慢性丙型肝炎病毒感染血液透析患者中的隐匿性乙型肝炎病毒感染
J Nephrol. 2006 May-Jun;19(3):327-33.
5
Hepatitis B surface antigen-positive but DNA-negative patients.乙肝表面抗原阳性但DNA阴性的患者。
Semin Dial. 2001 May-Jun;14(3):230-1. doi: 10.1046/j.1525-139x.2001.00057-4.x.
6
Occult Hepatitis B Virus Infection With Increased Virus DNA Levels in a Chronic Hemodialysis Patient.一名慢性血液透析患者隐匿性乙型肝炎病毒感染且病毒DNA水平升高
Ther Apher Dial. 2018 Feb;22(1):91-92. doi: 10.1111/1744-9987.12595. Epub 2017 Sep 14.
7
Screening for hepatitis B, C and HIV infection among patients on haemodialysis (cross sectional analysis among patients from two dialysis units in the period January to July 2005).血液透析患者中乙型肝炎、丙型肝炎和艾滋病毒感染的筛查(2005年1月至7月期间对两个透析单位患者的横断面分析)
Prilozi. 2009 Dec;30(2):159-74.
8
Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.希腊中部血液透析患者隐匿性乙型肝炎病毒感染的流行情况。
World J Gastroenterol. 2010 Jan 14;16(2):225-31. doi: 10.3748/wjg.v16.i2.225.
9
Hepatitis virus infection in haemodialysis patients from Moldavia.摩尔多瓦血液透析患者中的肝炎病毒感染
Nephrol Dial Transplant. 1999 Jan;14(1):40-5. doi: 10.1093/ndt/14.1.40.
10
[Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].[采用血清学和分子方法对血液透析患者进行乙型和丙型肝炎病毒感染调查]
Mikrobiyol Bul. 2014 Jan;48(1):143-50.

引用本文的文献

1
Serological and molecular characterization of hepatitis B virus infection in chronic kidney disease patients from Rio de Janeiro, Brazil.巴西里约热内卢慢性肾脏病患者乙型肝炎病毒感染的血清学和分子特征。
Braz J Infect Dis. 2022 May-Jun;26(3):102371. doi: 10.1016/j.bjid.2022.102371. Epub 2022 May 31.
2
An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates.在阿拉伯联合酋长国,对接受透析治疗的患者接种国药控股 HB02 新冠疫苗后的抗体反应和临床后遗症进行分析。
Nephrology (Carlton). 2022 Mar;27(3):260-268. doi: 10.1111/nep.13980. Epub 2021 Oct 5.
3
Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody.
阿联酋阿布扎比接受透析治疗的终末期肾病合并 COVID-19 患者的结局:从 PCR 到抗体。
BMC Nephrol. 2021 May 26;22(1):198. doi: 10.1186/s12882-021-02378-y.